NCT00582283View on ClinicalTrials.gov

NM404 as an Imaging Agent in Patients With NSCLC

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 14, 2004

Primary Completion Date

August 1, 2014

Study Completion Date

August 1, 2014

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

I124-NM404

I-124-NM404

Trial Locations (1)

53792

University of Wisconsin Carbone Comprehensive Cancer Center, Madison

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Cellectar Biosciences, Inc.

INDUSTRY

lead

University of Wisconsin, Madison

OTHER